ClinConnect ClinConnect Logo
Search / Trial NCT06679088

GlyCoBrain Observational Study

Launched by PADERBORN UNIVERSITY · Nov 5, 2024

Trial Information

Current as of June 27, 2025

Enrolling by invitation

Keywords

Chronotype Breakfast Glyceamic Index Mctq Academic Performance Dietary Patterns Student Nutrition Nutrient Composition

ClinConnect Summary

Background Breakfast is commonly considered one of the most important meals of the days. Failure to consume a breakfast, i.e., breakfast skipping, has been related to an increased risk of overweight/obesity or type 2 diabetes in the longer-term, but may also adversely affect cognition and academic performance. Similarly, breakfasts with a high glycaemic index (GI) resulting in sharp rises in blood glucose may adversely affect memory and attention, particularly in the late postprandial phase (i.e., 120-180 minutes after breakfast). A recent meta-analysis suggests specific effects for immedia...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Students at Paderborn University aged between 18 and 25 years
  • Proficient in the German language because all questionnaires are in German.
  • Exclusion Criteria:
  • Students studying nutritional science and home economics
  • * acute or permanent use of sleep-promoting medications (including herbal preparation):
  • chemical medications: melatonin, diphenhydramine, doxylamine
  • herbal preparations: hops, St. John's wort, lemon balm, lavender, passionflower, Baldurat, Neurexan, cannabinoids
  • Use of psychotropic medications (antidepressants, tranquilizer, antipsychotics)
  • Use of methylphenidate (e.g. Ritalin, Medikinet, Concerta)
  • Use of cannabinoids by prescription
  • Continuous administration of antihistamines when discontinuation is not feasible during the intervention
  • Use of herbal preparations affecting memory and concentration (e.g. gingko, ginseng, ashwagandha)
  • Use of other medications (e.g. insulin, metformin, SGLT2 inhibitors, steroids, ACE inhibitors)
  • Selected chronic diseases (depression and other mental disorders such as anxiety disorder, ADHD, diabetes mellitus (all types), prediabetes, blood clotting disorders (e.g., thrombocytopenia, hemophilia), eating disorders (e.g., anorexia, binge eating, bulimia)
  • Addiction disorders (e.g., alcohol, drug, or medication dependency)
  • Chronic inflammatory bowel diseases
  • infectious diseases (HIV, hepatitis)
  • Pregnant and breastfeeding individuals
  • Shift work or travel in the past 3 months across more than 2 time zones
  • students with a pacemaker/defibrillator

About Paderborn University

Paderborn University, a leading institution in research and education located in Germany, is committed to advancing scientific knowledge and improving healthcare outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its expertise in various fields, including medicine, engineering, and social sciences, to design and implement rigorous research studies. Paderborn University is dedicated to ensuring the highest ethical standards and regulatory compliance in its clinical trials, aiming to contribute valuable insights that enhance patient care and inform future medical practices.

Locations

Paderborn, North Rhine Westfalia, Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported